Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchglp-1obesityatrial fibrillationsleep apnea

Cureus Case Report Details GLP-1 Therapy in Morbid Obesity

A single patient with paroxysmal atrial fibrillation, severe osteoarthritis and sleep apnea started a GLP-1 agonist plus lifestyle changes.

PR
By Priya Raman · Science Reporter
Sep 15 14:38 ETSource: Cureus

The wire

  1. 01Cureus published a case report on GLP-1 initiation with lifestyle modification in a multimorbid obesity patient.
  2. 02Case adds anecdotal detail on GLP-1 use amid cardiac, joint and respiratory comorbidities.
  3. 03Single-case evidence; outcomes cannot be generalized and no comparator exists.

From the source

Initiation of Glucagon-Like Peptide-1 Receptor Agonist Therapy and Lifestyle Modifications for Morbid Obesity in a Patient With Paroxysmal Atrial Fibrillation, Severe Osteoarthritis, and Obstructive Sleep Apnea: A Case Report

Read at news.google.com